A cannabis high... really ?

Pininvest Analysis on Health Care

High expectations for exponentially growing cannabis demand rely presumably on the extrapolation of sales in liberal US States ... but are blurred lines between medical uses and recreation a recipe for enduring mainstream success ?

1 more article in Cannabis meanderings

COVID-19 Vaccines

Pininvest Analysis on Health Care

Chaos seems pre-ordained in FDA approval processes of numerous candidate vaccines. With a fluid reference to 'efficacy', the FDA is expected to deliver emergency authorizations within months, followed by rigorous and extensive year-long studies

2 more articles in Chronic Diseases

Dr. Moll's challenge

Pininvest Analysis on Health Care

The achievements of Fred Moll in medical robotics are close to legendary but the collaboration of Dr. Moll with Johnson & Johnson, may raise the bar, with real-time management of the data feeds informing the robotics applications - the next frontier...

6 more articles in Medical Robotics
3 more articles in Pharmaceuticals Majors

Challenging times for Celgene

Pininvest Analysis on Health Care

Revlimid, a drug for multiple myeloma, is the main stay of Celgene’s business (approx. 2/3 of 2017 $13bn turnover) – the drug also highlights the challenges of large biopharmaceutical companies priced for growth